Nivolumab-Induced Fulminant Autoimmune Diabetes Presenting as Diabetic Ketoacidosis in a Patient With Melanoma
Metabolism: Clinical and Experimental - Netherlands
doi 10.1016/j.metabol.2019.12.010
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2020
Authors
Publisher
Elsevier BV